Web www.software-risk.co.uk

Pharmacopeia Drug Discovery has appointed Michio "Mich" Soga as Chief Financial Officer (CFO).

He has been at Goldman Sachs, Morgan Stanley and Credit Agricole Indosuez.

Through a broad search, Pharmacopeia sought an experienced financial professional with expertise to complement our team. We have found an ideal match in Mich, said Les Browne, Ph.D., President and Chief Executive Officer of Pharmacopeia. "His strategic thinking and successful track record in investment banking will prove highly valuable as we continue to build Pharmacopeia's pharmaceutical development business and advance our internal portfolio of therapeutic candidates."

Pharmacopeia creates and delivers novel therapeutics to address significant medical needs. Using proprietary technologies and processes, Pharmacopeia discovers and develops novel drug candidates to advance internally as well as with strategic partners.

Related Articles
Hoopes Appointed CFO at Catcher
Elemental Security Names New CFO
Former WorldCom CFO Settles
NEP Broadcasting Announces Bart R. Huchel as CFO
Financial Job Growth Fuelled by Sarbanes-Oxley
Smith Micro New CFO
CFOs Call For Leeway on SOX
Agilysys and IMSI SOX News

Similar Areas

Health & Social Care Items

Sarbanes-Oxley Items

Finance Items

Management Items

Regulation Items

Selected Books

Keywords

Pharmacopeia

Pharmacopeia drug discovery

CFO

Chief Financial Officer

Sarbanes-Oxley and CFO

Sarbanse-Oxley and Chief Financial Officer

Sarbanes-Oxley and pharma

Sarbanes-Oxley and drugs

Sarbanes-Oxley and executives